ABEO
NASDAQ · Biotechnology
Abeona Therapeutics Inc
$5.68
-0.18 (-3.07%)
Open$5.83
Previous Close$5.86
Day High$5.83
Day Low$5.58
52W High$7.54
52W Low$4.00
Volume—
Avg Volume1.44M
Market Cap315.47M
P/E Ratio4.43
EPS$0.93
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+148.1% upside
Current
$5.68
$5.68
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.89M | 3.05M | 39.71M |
| Net Income | 59.78M | 33.54M | -4,431,314 |
| Profit Margin | 1,223.1% | 1,161.9% | -11.2% |
| EBITDA | 60.48M | 35.82M | -4,969,444 |
| Free Cash Flow | — | — | -4,447,710 |
| Rev Growth | +60.4% | +60.4% | +12.5% |
| Debt/Equity | 0.13 | 0.13 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |